Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM, EGM Calendar - Week Ahead

Tue, 17th May 2016 15:11

AGM, EGM Calendar
Wednesday, May 18
UBM
Jupiter Fund Management
Antofagasta
Paddy Power Betfair
Circassia Pharmaceuticals
ProPhotonix
STM Group 
Satellite Solutions Worldwide
CPPGroup
Vitec Group
Safecharge International
European REIT
Panmure Gordon & Co
Marshalls
Circle Holdings
Bankers Petroleum
Frenkel Topping Group
Johnston Press 
Stilo International
Foxtons Group
Xaar
Rathbone Brothers
Skyepharma
Chesnara
Playtech
Zotefoams
Thursday, May 19
Next
Merlin Entertainments
Informa
Balfour Beatty
Prudential
StatPro Group
Computacenter
PPHE Hotel Group
ProPhotonix
Sherborne Investors
Cineworld Group
Learning Technologies
Revolymer
Crossrider
Science Group
Safestyle UK
GLI Finance
Staffline Group
Riverstone Energy
Gamma Communications
Glencore
Petrofac
HaloSource (re recreational water business sale)
Ferrexpo
North Midland Construction
Portmeiron Group
Concurrent Technology
Game Digital (re loan facility with Lajedosa Investments)
Conviviality (re acquisition of Bibendum PLB & proposed placing)
Exova Group
LMS Capital
PV Crystalox Solar
Hiscox
Friday, May 20
Spectris
Moss Bros Group
Applegreen
Richland Resources
Snacktime
Hydrogen Group
John Menzies
Hochschild Mining
Vislink
Headlam Group
Baillie Gifford Shin Nippon
Spectris
Monday, May 23
Restore
Stock Spirits Group
Noricum Gold
Nasstar
4D Pharma
Hvivo
Plant Healthcare
Synety Group
Vertu Capital
Tuesday, May 24
Marshall Motor Holdings
Royal Dutch Shell
Metro Bank
Card Factory
Ranger Direct Lending
Accesso Technology Group 
Epwin Group
Belgravium Technologies
GVC Holdings
Merchants Trust
Keller Group
Telit Communications
Quarto Group
 
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
14 May 2018 16:11

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 15 MayAmerisur ResourcesMacfarlane GroupSpirax-Sarco EngineeringAnglo Pacific

Read more
8 May 2018 10:02

4D Pharma Sets Up Phase Two Study For Bowel Syndrome Treatment Blautix

LONDON (Alliance News) - Biotherapeutics developer 4D Pharma PLC said on Tuesday that the US Food & Drug Administration has cleared the Investigational New Drug Application for irritable bowel

Read more
23 Apr 2018 09:47

4D Pharma Loss In 2017 Widens On Higher Research And Development Costs

LONDON (Alliance News) - Drug development firm 4D Pharma PLC said Monday its loss widened in 2017 on higher research and development costs as it continued to progress its pipeline and clinical in

Read more
21 Mar 2018 09:12

4D Pharma To Shortly Begin Clinical Studies On MRx0518 Treatment

LONDON (Alliance News) - 4D Pharma PLC on Wednesday said it is close to starting clinical studies on its potential MRx0518 cancer treatment.MRx0518 is a single strain a

Read more
13 Dec 2016 07:54

4D Pharma Reports Encouraging Results From Blautix Phase 1 Trial

Read more
30 Sep 2016 06:51

4D Pharma Loss Narrows As Operating And Research Costs Fall

Read more
22 Aug 2016 11:57

4D Pharma begins Thetanix phase 1 clinical trial

(ShareCast News) - Pharmaceutical company 4D pharma has begun dosing in a phase 1 clinical trial with Thetanix for the treatment of Paediatric Crohn's disease (PCD). PCD is a rare chronic inflammatory bowel disease that is caused by the malfunction of the immune system leading to inflammation, or sw

Read more
19 Jul 2016 10:00

4D Pharma announces encouraging first clinical trial of Blautix

(ShareCast News) - 4D Pharma announced a positive response from its Blautix treatment for irritable bowel syndrome (IBS) in a phase 1 clinical trial. The trial was a first in man study and, as previously reported by the company, Blautix was found to be both safe and well tolerated and achieved the p

Read more
19 Jul 2016 07:49

4D Pharma Says Positive First Trial Of Product Blautix "Encouraging"

Read more
10 Jun 2016 07:30

4D Pharma Gets Approval To Restart Thetanix Phase I Clinical Study

Read more
23 May 2016 12:49

4D Pharma irritable bowel treatment proves safe in clinical trial

(ShareCast News) - Early clinical trials of 4D Pharma's treatment for irritable bowel syndrome (IBS) have successfully shown Blautix to be safe and well tolerated. Blautix, which contains live bacteria, like all 4D's products, was delivered orally to 56 healthy volunteers and IBS patients. Data fro

Read more
23 May 2016 06:58

4d Pharma Says Blautix Treatment Meets Primary Endpoint In Trial

Read more
16 May 2016 15:10

AGM, EGM Calendar - Week Ahead

Read more
8 Apr 2016 16:17

4D Pharma gobbles up Biomar production assets

(ShareCast News) - 4D Pharma announced a major acquisition on Friday, gobbling up the production assets of Spanish-based contract research organisation Biomar. The AIM-traded pharmaceutical company, which focuses on the development of live biotherapeutics, said Biomar had been working as an outsourc

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.